Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Health Technology Group Holding Co's revenue for the
six
months ended in Dec. 2025 was $4.88 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $13.11 Mil.
China Health Technology Group Holding Co's Revenue per Share for the
six
months ended in Dec. 2025 was $0.04.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.12.
Warning Sign:
China Health Technology Group Holding Co Ltd revenue per share has been in decline for the last 5 years.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
China Health Technology Group Holding Co Revenue Related Terms
China Health Technology Group Holding Co Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co Revenue Chart
China Health Technology Group Holding Co Annual Data
For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Technology Group Holding Co Revenue vs Forest Products Industry
China Health Technology Group Holding Co Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $13.11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co (CHBOF) has a Revenue of $13.11 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on China Health Technology Group Holding Co and its competitors.
Is China Health Technology Group Holding Co's Revenue too high?
China Health Technology Group Holding Co's current Revenue is $13.11 Mil. Overall, China Health Technology Group Holding Co has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's Revenue compare to SSD and UFPI?
China Health Technology Group Holding Co's Revenue of $13.11 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Forest Products company?
A good Revenue depends on the Forest Products industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on China Health Technology Group Holding Co and its competitors. China Health Technology Group Holding Co's current Revenue is $13.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current Revenue of $13.11 Mil. The stock's GF Value™ is $0.05, compared to a current price of $0.03 — trading 34.1% below its estimated fair value. The current Revenue is $13.11 Mil. China Health Technology Group Holding Co's overall GF Score™ is 28/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current Revenue is $13.11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued.
The current stock price of $0.03 is trading 34.1% below its estimated GF Value™ of $0.05.
Key valuation signals for CHBOF:
Revenue: $13.11 Mil
GF Value™: $0.05 vs. price of $0.03 (34.1% below fair value)
No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Technology Group Holding Co Business Description
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
28GF Score
Get the complete analysis for CHBOF
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHBOF has been successfully added to your 
